Literature DB >> 25208495

Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis.

Tee Joo Yeo1, Poh Shuan Daniel Yeo, Raymond Ching-Chiew Wong, Hean Yee Ong, Kui Toh Gerard Leong, Fazlur Jaufeerally, David Sim, Rajalakshmi Santhanakrishnan, Shir Lynn Lim, Michelle M Y Chan, Ping Chai, Adrian F Low, Lieng H Ling, Tze Pin Ng, A Mark Richards, Carolyn S P Lam.   

Abstract

AIMS: Current heart failure (HF) guidelines highlight the importance of iron deficiency (ID) in HF. Whether HF itself or age-related comorbidities contribute to ID is uncertain, and previous data were limited to Western populations. We aimed to study the prevalence, clinical correlates, functional significance and prognosis of ID in HF patients, compared with community-based controls in a multi-ethnic Southeast Asian population. METHODS AND
RESULTS: Iron status was assessed in 751 HF patients (age 62.0 ± 12.2 years, 75.5% men, 64.7% Chinese, 23.9% Malay, 10.2% Indian) and 601 controls (age 56.9 ± 10.4 years, 49.8% men, 70.9% Chinese, 21.5% Malay, 7.2% Indian). ID, defined as ferritin <100 µg/L or ferritin 100-300 µg/L and transferrin saturation (Tsat) <20%, was present in 39.3% of controls and 61.4% of HF [odds ratio (OR) 3.5, 95% confidence interval (CI) 2.5-4.9, adjusting for clinical covariates]. Independent correlates of ID in HF were Indian ethnicity (OR 2.4 vs. Chinese, 95% CI 1.2-5.0), female gender (OR 2.8, 95% CI 1.7-4.8), larger body mass index (OR 1.05/unit increase, 95% CI 1.01-1.1) and decreased left ventricular ejection fraction (OR 1.03/unit decrease, 95% CI 1.01-1.04). In a subset of 48 HF patients undergoing cardiopulmonary exercise testing, Tsat correlated with peak oxygen consumption (ρ = 0.53, P < 0.01), independent of baseline characteristics. The HF patients with Tsat <20% as well as anaemia showed the poorest event-free survival after adjusting for clinical covariates.
CONCLUSIONS: ID was highly prevalent and independently related to functional capacity and outcomes in our cohort. These findings suggest a pathophysiological role of ID in HF and support its importance as a therapeutic target in Southeast Asian patients with HF.
© 2014 The Authors. European Journal of Heart Failure © 2014 European Society of Cardiology.

Entities:  

Keywords:  Exercise capacity; Heart failure; Iron deficiency

Mesh:

Substances:

Year:  2014        PMID: 25208495     DOI: 10.1002/ejhf.161

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  32 in total

Review 1.  Towards Holistic Heart Failure Management-How to Tackle the Iron Deficiency Epidemic?

Authors:  Lucas N L Van Aelst; Dominiek Mazure; Alain Cohen-Solal
Journal:  Curr Heart Fail Rep       Date:  2017-08

2.  Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study.

Authors:  Odilson M Silvestre; Alexandra Gonçalves; Wilson Nadruz; Brian Claggett; David Couper; John H Eckfeldt; James S Pankow; Stefan D Anker; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2016-12-14       Impact factor: 15.534

Review 3.  Iron in kidney and heart failure: from theory to practice.

Authors:  Aslihan Yerlikaya; Mustafa C Bulbul; Baris Afsar; Tuncay Dagel; Gamze Aslan; Luminita Voroneanu; Dimitire Siriopol; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2017-09-22       Impact factor: 2.370

Review 4.  Publication trends in cachexia and sarcopenia in elderly heart failure patients.

Authors:  Jochen Springer; Stefan D Anker
Journal:  Wien Klin Wochenschr       Date:  2016-11-24       Impact factor: 1.704

5.  Intravenous Iron-Carbohydrate Nanoparticles and Their Similars. What Do We Choose?

Authors:  Ana Maria Mehedinti; Cristina Capusa; Iuliana Andreiana; Gabriel Mircescu
Journal:  Maedica (Bucur)       Date:  2022-06

Review 6.  Iron Therapy in Heart Failure: Ready for Primetime?

Authors:  Ify R Mordi; Aaron Tee; Chim C Lang
Journal:  Card Fail Rev       Date:  2018-05

Review 7.  Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?

Authors:  Donald S Silverberg; Dov Wexler; Doron Schwartz
Journal:  Int J Mol Sci       Date:  2015-06-18       Impact factor: 5.923

8.  Rationale and design of a pilot randomized controlled trial to assess the role of intravenous ferric carboxymaltose in Asian patients with heart failure (PRACTICE-ASIA-HF).

Authors:  Tee Joo Yeo; Poh Shuan Daniel Yeo; Farid Abdul Hadi; Timothy Cushway; Kim Yee Lee; Bee Choo Tai; Carolyn S P Lam
Journal:  ESC Heart Fail       Date:  2015-12-16

9.  Prevalence and spectrum of iron deficiency in heart failure patients in south Rajasthan.

Authors:  Sohan Kumar Sharma; Shalabh Kumar Agarwal; Kapil Bhargava; Mukesh Sharma; Karan Chopra; Gopinath Arumugam
Journal:  Indian Heart J       Date:  2016-01-11

10.  Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort.

Authors:  Ya-Nan Zhang; Flora Vernooij; Irwani Ibrahim; Shirley Ooi; Crystel M Gijsberts; Arjan H Schoneveld; Kuan Win Sen; Hester M den Ruijter; Leo Timmers; Arthur Mark Richards; Chun Tzen Jong; Ibrahim Mazlan; Jiong-Wei Wang; Carolyn S P Lam; Dominique P V de Kleijn
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.